... Systemic effects ofchronicobstructivepulmonarydisease Eur Respir J potential impact of anaemia ofchronicdisease in COPD Eur Respir J HT E D between chronicobstructivepulmonarydisease and ... activity in chronicobstructivepulmonarydisease N Engl J Med exercise intolerance in chronicobstructivepulmonarydisease Am J Respir Crit Care Med L- chronicobstructivepulmonarydisease Eur ... Active detection ofchronicobstructivepulmonarydisease and asthma in the ofdisease burden that are consistent and measurable across nations The authors of the Global Burden ofDisease Study...
... Zielinski J, Global Initiative forChronicObstructive Lung Disease: Global strategy for the diagnosis, management, and prevention ofchronicobstructivepulmonary disease: GOLD executive summary ... TF: New strains of bacteria and exacerbations ofchronicobstructivepulmonarydisease N Engl J Med 2002, 347:465-471 Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA: Relation of sputum inflammatory ... with chronicobstructivepulmonarydisease Thorax 2005, 60:925-931 Andersson F, Borg S, Jansson SA, Jonsson AC, Ericsson A, Prütz C, Rönmark E, Lundbäck B: The costs of exacerbations in chronic obstructive...
... Microbiologic determinants of exacerbation in chronicobstructivepulmonarydisease Arch Intern Med 2005, 165:891-897 Miravitlles M: Exacerbations ofchronicobstructivepulmonary disease: when are bacteria ... exacerbations ofchronicobstructivepulmonarydisease Am J Respir Crit Care Med 2007, 176:356-361 28 Sethi S, Evans N, Grant BJ, Murphy TF: New strains of bacteria and exacerbations ofchronicobstructive ... validation of the significance of sputum purulence in severe exacerbations ofchronicobstructivepulmonarydisease Thorax 2006, 62:29-35 32 Wilson R: Using antibiotics to delay exacerbations of chronic...
... Vestbo J: The natural history ofchronicobstructivepulmonarydisease Eur Respir J 2006, 27(3):627-643 Agusti A: Systemic effects ofchronicobstructivepulmonary disease: what we know and what ... molecules at both the protein and gene level would form the basisof a molecular fingerprint of COPD for use in disease diagnosis Page of 17 (page number not for citation purposes) Respiratory Research ... with chronicobstructivepulmonarydisease with or without glucocorticoid therapy Eur Respir J 1998, 11(1):41-45 Gomez FP, Rodriguez-Roisin R: Global Initiative forChronicObstructive Lung Disease...
... exacerbations ofchronicobstructivepulmonary disease: Cochrane systematic review and meta-analysis BMJ 2003, 326:185-187 Babu KS, Chauhan AJ: Non-invasive ventilation in chronicobstructivepulmonarydisease ... chronicobstructivepulmonary disease: correlates for success Thorax 1995, 50:755-757 Soo Hoo GW, Santiago S, Williams J: Nasal mechanical ventilation for hypercapnic respiratory failure in chronic ... efficacy of NPPV to the refinement of selection and application techniques with the aim of minimizing the failure rate Potential reasons for failure include selection of inappropriate candidates for...
... obstructivepulmonarydisease worldwide Monaldi Archives for Chest Disease 2001; 56: 261-264 Anto JM, Vermeire P, Vestbo J, Sunyer J Epidemiology ofchronicobstructivepulmonarydisease European ... understanding of the dimensions of this disease, both in terms of costs and prevalence Motivated by this concern, this analysis will examine the geographic distribution of COPD in California for the ... variables Zip code level information was then transformed into uniform grid information (as discussed at length below) for both time periods The asymmetric nature of the number of zip codes prompted...
... extension of mildly affected stroke patients with the help of a powered orthosis Following six weeks of training in reach-to-grasp of virtual and actual objects, patients' active motor performance ... in-patient rehabilitation programme forchronic stroke patients The rehab programme included 45 minutes each of Bobath orientated physiotherapy and occupational therapy every workday, of which ... for about 15 minutes Over weeks of treatment days/week, the distal tone reduction became persistent Both patients had a modified Ashworth score of 2/5 for the fingers, tested while supine before...
... Relationship of quality of life to sex, age, and severity of COPD Relationship of quality of life to sex, age, and severity of COPD Page of (page number not for citation purposes) Health and Quality of ... for the diagnosis, management, and prevention ofchronicobstructivepulmonarydisease NHLBI/WHO global iniciative forchronicobstructive lung disease (GOLD) workshop summary Am J Respir Crit ... patients with chronicobstructivepulmonarydisease Arch Intern Med 1982, 142:473-478 Okubadejo AA, Jones PW, Wedzicha JA: Quality of life in patients with chronicobstructivepulmonarydisease and...
... Journal of Medical Case Reports 2007, 1:91 Fibre-optic bronchoscopy was performed because of the haemoptysis This showed widespread inflammation of the endobronchial tree with ... Several patterns ofpulmonary damage can occur, with tracheobronchitis the most common manifestation Ulceration of the trachea may be associated with necrotizing pneumonia The surface of the ulcerated ... difficult to treat exacerbations of COPD may be underestimated Diagnosis may be considered in patients with chronic lung disease, especially during exacerbations of COPD who are not responding...
... of postrehabilitation programmes among individuals with chronicobstructivepulmonarydisease Eur Respir J 2002, 20:20-29 33 Ries AL, Kaplan RM, Limberg TM, Prewitt LM: Effects ofpulmonaryrehabilitation ... Universities Corticosteroids in Obstructive Lung Disease Study Group: Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronicobstructivepulmonary disease: a randomized trial ... [http://www.goldcopd.org] Lacasse Y, Goldstein R, Lasserson TJ, Martin S: Pulmonaryrehabilitationforchronicobstructivepulmonarydisease Cochrane Database of Systematic Reviews 2006, , 4: CD003793 Wijkstra PJ,...
... exacerbations ofchronicobstructivepulmonarydisease Annals of Internal Medicine 1987, 106(2):196-204 Publish with Bio Med Central and every scientist can read your work free of charge "BioMed ... Puhan MA, Vollenweider D, Latshang T, Steurer J, Steurer-Stey C: Exacerbations ofchronicobstructivepulmonary disease: when are antibiotics indicated? A systematic review Respiratory research ... number-needed to treat of 9, 95% CI 7–12) but there was a large amount of heterogeneity (I2 = 83%)." The corrected versions of Figures two and three are given here- see figures and We apologize for any inconvenience...
... series of randomized controlled trials (RCTs) of pharmacological treatment which have provided a strong evidence base for the role of drug treatment in the management ofchronicobstructivepulmonary ... reported AE, irrespective of GOLD stage, was an exacerbation of COPD The incidence of pneumonia increased with disease severity, irrespective of treatment The probability of pneumonia as an AE was ... speaking fees from AstraZeneca and Glaxo- Global Strategy for the Diagnosis, Management, and Prevention ofChronicObstructivePulmonaryDisease [http:// www.goldcopd.com] Calverley PM, Anderson...
... exacerbations of COPD: lessons from the past Eur Respir J 2004, 24(6):896-897 NICE: Chronicobstructivepulmonary disease: national clinical guideline for management ofchronicobstructivepulmonarydisease ... exacerbations ofchronicobstructivepulmonarydisease Clin Infect Dis 2004, 39(7):980-986 Saint S, Bent S, Vittinghoff E, Grady D: Antibiotics in chronicobstructivepulmonarydisease exacerbations ... Antibiotic therapy in exacerbations ofchronicobstructivepulmonarydisease Annals of Internal Medicine 1987, 106(2):196-204 Berry DGF J.;Hindley,C.P.: Exacerbations ofchronic bronchitis treatment...
... rise of COPD? Br J Gen Pract 2006, 56(530):652-654 National Collaborating Centre forChronic Conditions: Chronicobstructivepulmonarydisease National clinical guideline on management ofchronic ... Severe 8% Distribution of MRC dyspnoea score for different degrees of severity of airflow obstruction Figure Distribution of MRC dyspnoea score for different degrees of severity of airflow obstruction ... ofchronicobstructivepulmonarydisease in adults in primary and secondary care Thorax 2004, 59(Suppl 1):1-232 Global Initiative forChronicObstructive Lung Disease: Global strategy for the diagnosis,...
... The nature of small-airway obstruction in chronicobstructivepulmonarydisease N Engl J Med 2004, 350:2645-2653 Sin DD, Man SF: Why are patients with chronicobstructivepulmonarydisease at ... (FEV1 < 40% pred) had a higher risk of death from all causes (RR, 5.0 for women, 2.7 for men) and of deaths from obstructive lung diseases (RR, 57 for women, 34 for men,) compared with men [25] ... S, Wain J, Speizer FE: Genetic epidemiology of severe, early-onset chronicobstructivepulmonarydisease Risk to relatives for airflow obstruction and chronic bronchitis Am J Respir Crit Care Med...
... Hurd SS: Global strategy for the diagnosis, management, and prevention ofchronicobstructivepulmonarydisease NHLBI/WHO Global Initiative forChronicObstructive Lung Disease (GOLD) Workshop ... These models can be of significant help for the identification of both physiological functions of distinct genes as well as mechanisms of diseases such as COPD A large number of genetically-altered ... inflammation in chronicobstructivepulmonary disease* 1: Comparisons with asthma J Allergy Clin Immunol 2003, 112:819-827 Chung KF: Cytokines in chronicobstructivepulmonarydisease Eur Respir...
... 3) American Thoracic Society 4) A Joint panel of the American College of Chest Physicians and the American College of Physicians 5) A Joint panel of the national Heart, Lung and Blood Institute ... Blood Institute and the World health Organization (đợc biết dới tên Global Initiative forChronicObstructive Lung Disease hay GOLD) Nguyễn Đạt Anh 10 Chơng Hô hấp Tóm tắt phác đồ khuyến cáo bN đến ... hay (nh cefuroxime) Macrolide Clarithromycin Azithromycin (Zithromax) Quinolones Ciprofloxacin (Cipro) Levofloxacin (Levaquin) 250 -500 mg x lần/ngày 250 - 500 mg x 2lần/ngày 500 mg ngày đầu,...
... 3) American Thoracic Society 4) A Joint panel of the American College of Chest Physicians and the American College of Physicians 5) A Joint panel of the national Heart, Lung and Blood Institute ... Blood Institute and the World health Organization (đợc biết dới tên Global Initiative forChronicObstructive Lung Disease hay GOLD) Tóm tắt phác đồ khuyến cáo bN đến khoa cc trông nặng nhận định ... 500 mg ngày đầu, sau 250 mg/ngày x ngày tiếp Nguyễn Đạt Anh Chơng Hô hấp Quinolones Ciprofloxacin (Cipro) Levofloxacin (Levaquin) 500 -750 mg x lần/ngày 500 mg/ngày E corticosteroid Một số thử nghiệm...